A main milestone in drug development is the initiation of studies in humans. Studies with a new medicinal product require approval by regulatory authorities and ECs (Institutional Review Board: IRB). To take this step, the key information required includes the following:
Medicinal Product Human Data Drug Development Program Target Profile Convenient Dosage
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.